Starts as love, stays as science
StemCyte (stemcyte.com) scores 81 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 79th percentile of 16717 Healthcare brands.
StemCyte is a healthcare company founded in 1997 and headquartered in Baldwin Park, United States, specializing in cord blood banking and stem cell therapy science. The company helps expecting parents and families preserve their newborn's cord blood stem cells for potential future use in treating blood cancers, immune deficiencies, and other serious medical disorders. StemCyte positions itself as a trusted leader in the cord blood banking industry, combining the emotional significance of preserving a newborn's cells with their scientific and medical value for regenerative medicine applications.
| Brand Name | StemCyte |
|---|---|
| Domain | stemcyte.com |
| Industry | Healthcare |
| Founded | 1997 |
| Headquarters | Baldwin Park, United States |
| Main Competitors | Cord Blood Registry (77/100), ViaCord, Cryo-Cell International (81/100), CBR Systems (77/100), Americord Registry (78/100), Cord Blood America |
Moz Domain Authority 36/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Bank your baby" (Meta description too short (3 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 4 JSON-LD block(s), Organization schema, FAQ schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical.
AI-crawler access: robots.txt mentions GPTBot, ChatGPT-User, ClaudeBot, Google-Extended, PerplexityBot - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, HubSpot.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is StemCyte?", Claude could identify the brand as of October 2026. StemCyte is a cord blood banking and cell therapy company that collects, processes, and stores umbilical cord blood stem cell units for both private family banking and public donation, and it has also been involved in clinical research using cord blood for conditions like spinal Best known for being one of the larger global cord blood banks supplying stem cell units for transplants and research.
When asked "Best brands similar to StemCyte?", Claude would recommend StemCyte as of October 2026. It's a established, reasonably well known name in the cord blood banking space, so it would be reasonable to mention alongside other major cord blood banks.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
StemCyte's main competitors in Healthcare: Cord Blood Registry (77/100), Cryo-Cell International (81/100), CBR Systems (77/100), Americord Registry (78/100).
Sources: Brand Analyzer scan
StemCyte has limited AI-search visibility, scoring 45/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 65, recommendation 66). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: StemCyte official site
StemCyte was founded in 1997. StemCyte operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
StemCyte offers cord blood banking services, allowing families to collect and preserve their newborn's cord blood stem cells. These preserved cells can potentially be used in stem cell therapy for treating blood cancers, immune deficiencies, and other serious medical conditions.
Sources: StemCyte official site
StemCyte scores 66/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: StemCyte official site
StemCyte is a healthcare company, founded in 1997 and headquartered in Baldwin Park, United States, that specializes in cord blood banking and stem cell therapy science. It focuses on preserving newborn cord blood stem cells to provide families with potential access to regenerative medicine treatments.
Sources: StemCyte official site
StemCyte collects, processes, and preserves cord blood stem cells from newborns, enabling families to store these cells for potential future use. The company combines cord blood banking expertise with stem cell therapy science to support treatments for blood cancers, immune deficiencies, and other serious medical disorders.
Sources: StemCyte official site
StemCyte can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: StemCyte official site
StemCyte's services are used by expecting parents and families who are interested in safeguarding their newborn's health through cord blood banking and exploring regenerative medicine options for potential future medical needs.
Sources: StemCyte official site
StemCyte is known for its expertise in cord blood banking, positioning itself as a trusted leader in preserving newborn stem cells for use in regenerative medicine and treatment of serious disorders such as blood cancers and immune deficiencies.
Sources: StemCyte official site
StemCyte scores 45/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
StemCyte has a limited AI-visibility profile at 45/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (66/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and a low Moz Domain Authority of 36/100. In a live check, Claude could already identify StemCyte from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to StemCyte: Star Health Insurance (81/100), Scleroderma and Raynaud's UK (81/100), Stiltz (81/100), Stony Brook Medicine (81/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.